(1)

Regulation (EU) 2021/953 lays down a framework for the issuance, verification and acceptance of interoperable COVID-19 vaccination, test and recovery certificates (‘EU Digital COVID Certificate’) for the purpose of facilitating the holders’ exercise of their right to free movement during the COVID-19 pandemic. It is also to contribute to facilitating the gradual lifting of restrictions to free movement put in place by Member States, in accordance with Union law, to limit the spread of SARS-CoV-2, in a coordinated manner.

(2)

Regulation (EU) 2021/953 allows for the acceptance of COVID-19 certificates issued by third countries to Union citizens and their family members where the Commission finds that those COVID-19 certificates are issued in accordance with standards that are to be considered as equivalent to those established pursuant to that Regulation. Furthermore, in accordance with Regulation (EU) 2021/954 of the European Parliament and of the Council (2), Member States are to apply the rules laid down in Regulation (EU) 2021/953 to third-country nationals who do not fall within the scope of that Regulation, but who are legally staying or residing in their territory and who are entitled to travel to other Member States in accordance with Union law. Therefore, any equivalence findings laid down in this Decision should apply to COVID-19 vaccination certificates issued by the Republic of Lebanon to Union citizens and their family members. Similarly, on the basis of Regulation (EU) 2021/954, such equivalence findings should also apply to COVID-19 vaccination certificates issued by the Republic of Lebanon to third-country nationals legally staying or residing in the territory of the Member States under the conditions laid down in that Regulation.

(3)

On 12 October 2021, the Republic of Lebanon provided the Commission with detailed information on the issuance of interoperable COVID-19 vaccination certificates under the system entitled ‘covax.moph.gov.lb’. The Republic of Lebanon informed the Commission that it considered that its COVID-19 certificates are being issued in accordance with a standard and a technological system, that are interoperable with the trust framework established by Regulation (EU) 2021/953 and that allow for the verification of the authenticity, validity and integrity of the certificates. In this regard, the Republic of Lebanon informed the Commission that COVID-19 vaccination certificates issued by the Republic of Lebanon in accordance with the ‘covax.moph.gov.lb’ system contain the data set out in the Annex to Regulation (EU) 2021/953.

(4)

The Republic of Lebanon also informed the Commission that it accepts vaccination, test and recovery certificates issued by the Member States and EEA countries in accordance with Regulation (EU) 2021/953.

(5)

On 26 November 2021, following a request by the Republic of Lebanon, the Commission carried out technical tests that demonstrated that the COVID-19 vaccination certificates issued by the Republic of Lebanon are in accordance with a system, the ‘covax.moph.gov.lb’, that is interoperable with the trust framework established by Regulation (EU) 2021/953, and allows for the verification of the authenticity, validity and integrity of the certificates. The Commission also confirmed that the COVID-19 vaccination certificates issued by the Republic of Lebanon in accordance with the ‘covax.moph.gov.lb’ system contain the necessary data.

(6)

In addition, the Republic of Lebanon informed the Commission that it issues interoperable vaccination certificates for COVID-19 vaccines. Those vaccines currently include Comirnaty, Vaxzevria, R-COVI, Sputnik V and BBIBP-CorV.

(7)

The Republic of Lebanon also informed the Commission that it does not issue interoperable test certificates either for nucleic acid amplification tests or rapid antigen tests.

(8)

Furthermore, the Republic of Lebanon informed the Commission that it does not issue interoperable certificates of recovery.

(9)

In addition, the Republic of Lebanon informed the Commission that when verifiers in Lebanon verify certificates, the personal data included in them will be processed only to verify and confirm the holder’s vaccination, test result or recovery status and will not be retained afterwards.

(10)

The necessary elements for establishing that COVID-19 vaccination certificates issued by the Republic of Lebanon in accordance with the ‘covax.moph.gov.lb’ system are to be considered as equivalent to those issued in accordance with Regulation (EU) 2021/953 are thus fulfilled.

(11)

Therefore, COVID-19 vaccination certificates issued by the Republic of Lebanon in accordance with the ‘covax.moph.gov.lb’ system should be accepted under the conditions referred to in Article 5(5) of Regulation (EU) 2021/953.

(12)

In order for this Decision to be operational, the Republic of Lebanon should be connected to the EU Digital COVID Certificate trust framework established by Regulation (EU) 2021/953.

(13)

In order to protect the Union’s interests, in particular in the area of public health, the Commission may use its powers to suspend application of this Decision or repeal it, if the conditions of Article 8(2) of Regulation (EU) 2021/953 are no longer met.

(14)

In order to connect the Republic of Lebanon to the EU Digital COVID Certificate trust framework established by Regulation (EU) 2021/953 as rapidly as possible, this Decision should enter into force on the day of its publication in the Official Journal of the European Union.

(15)

The measures provided for in this Decision are in accordance with the opinion of the Committee established by Article 14 of Regulation (EU) 2021/953,

(1)

Regulation (EU) 2021/953 lays down a framework for the issuance, verification and acceptance of interoperable COVID-19 vaccination, test and recovery certificates (‘EU Digital COVID Certificate’) for the purpose of facilitating the holders’ exercise of their right to free movement during the COVID-19 pandemic. It is also to contribute to facilitating the gradual lifting of restrictions to free movement put in place by Member States, in accordance with Union law, to limit the spread of SARS-CoV-2, in a coordinated manner.

(2)

Regulation (EU) 2021/953 allows for the acceptance of COVID-19 certificates issued by third countries to Union citizens and their family members where the Commission finds that those COVID-19 certificates are issued in accordance with standards that are to be considered as equivalent to those established pursuant to that Regulation. Furthermore, in accordance with Regulation (EU) 2021/954 of the European Parliament and of the Council (2), Member States have to apply the rules laid down in Regulation (EU) 2021/953 to third-country nationals who do not fall within the scope of that Regulation, but who are legally staying or residing in their territory and who are entitled to travel to other Member States in accordance with Union law. Therefore, any equivalence findings laid down in this Decision should apply to COVID-19 vaccination and test certificates issued by the United Arab Emirates to Union citizens and their family members. Similarly, on the basis of Regulation (EU) 2021/954, such equivalence findings should also apply to COVID-19 vaccination and test certificates issued by the United Arab Emirates to third-country nationals legally staying or residing in the territory of the Member States under the conditions laid down in that Regulation.

(3)

On 16 September 2021, the United Arab Emirates provided the Commission with detailed information on the issuance of interoperable COVID-19 vaccination and test certificates under the system entitled ‘Alhosn EU Pass’. The United Arab Emirates informed the Commission that it considered that its COVID-19 certificates are being issued in accordance with a standard and a technological system, that are interoperable with the trust framework established by Regulation (EU) 2021/953 and that allow for the verification of the authenticity, validity and integrity of the certificates. In this regard, the United Arab Emirates informed the Commission that COVID-19 certificates issued by the United Arab Emirates in accordance with the ‘Alhosn EU Pass’ system contain the data set out in the Annex to Regulation (EU) 2021/953.

(4)

The United Arab Emirates also informed the Commission that it accepts vaccination and test certificates issued by the Member States and EEA countries in accordance with Regulation (EU) 2021/953.

(5)

On 20 October 2021, following a request by United Arab Emirates, the Commission carried out technical tests that demonstrated that the COVID-19 vaccination and test certificates are issued by the United Arab Emirates in accordance with a system, the ‘Alhosn EU Pass’, that is interoperable with the trust framework established by Regulation (EU) 2021/953, and that allows for the verification of the authenticity, validity and integrity of the certificates. The Commission also confirmed that the COVID-19 vaccination and test certificates issued by the United Arab Emirates in accordance with the ‘Alhosn EU Pass’ system contain the necessary data.

(6)

In addition, the United Arab Emirates informed the Commission that it issues interoperable vaccination certificates for COVID-19 vaccines. These currently include Comirnaty, Spikevax, Covishield, COVID-19 Vaccine Janssen, NVX-CoV2373, Sputnik V, WIBP-CorV, BBIBP-CorV, Hayat-Vax and CoronaVac.

(7)

The United Arab Emirates also informed the Commission that it issues interoperable test certificates for nucleic acid amplification tests but it does not issue rapid antigen tests.

(8)

Furthermore, the United Arab Emirates informed the Commission that it does not issue interoperable certificates of recovery.

(9)

In addition, the United Arab Emirates informed the Commission that when verifiers in the United Arab Emirates verify certificates, the personal data included in them will be processed only to verify and confirm the holder’s vaccination and test result and will not be retained afterwards.

(10)

The necessary elements for establishing that COVID-19 certificates issued by the United Arab Emirates in accordance with the ‘Alhosn EU Pass’ system are to be considered as equivalent to those issued in accordance with Regulation (EU) 2021/953 and are thus fulfilled.

(11)

Therefore, COVID-19 certificates issued by the United Arab Emirates in accordance with the ‘Alhosn EU Pass’ system should be accepted under the conditions referred to in Article 5(5) and Article 6(5) of Regulation (EU) 2021/953.

(12)

In order for this Decision to be operational, the United Arab Emirates should be connected to the EU Digital COVID Certificate trust framework established by Regulation (EU) 2021/953.

(13)

In order to protect the Union’s interests, in particular in the area of public health, the Commission may use its powers to suspend application of this Decision or repeal it, if the conditions of Article 8(2) of Regulation (EU) 2021/953 are no longer met.

(14)

In the light of the need to connect the United Arab Emirates to the EU Digital COVID Certificate trust framework established by Regulation (EU) 2021/953 as rapidly as possible, this Decision should enter into force on the day of its publication in the Official Journal of the European Union.

(15)

The measures provided for in this Decision are in accordance with the opinion of the Committee established by Article 14 of Regulation (EU) 2021/953,

(1)

Regulation (EU) 2021/953 lays down a framework for the issuance, verification and acceptance of interoperable COVID-19 vaccination, test and recovery certificates (‘EU Digital COVID Certificate’) for the purpose of facilitating the holders’ exercise of their right to free movement during the COVID-19 pandemic. It is also to contribute to facilitating the gradual lifting of restrictions to free movement put in place by Member States, in accordance with Union law, to limit the spread of SARS-CoV-2, in a coordinated manner.

(2)

Regulation (EU) 2021/953 allows for the acceptance of COVID-19 certificates issued by third countries to Union citizens and their family members where the Commission finds that those COVID-19 certificates are issued in accordance with standards that are to be considered as equivalent to those established pursuant to that Regulation. Furthermore, in accordance with Regulation (EU) 2021/954 of the European Parliament and of the Council (2), Member States are to apply the rules laid down in Regulation (EU) 2021/953 to third-country nationals who do not fall within the scope of that Regulation, but who are legally staying or residing in their territory and who are entitled to travel to other Member States in accordance with Union law. Therefore, any equivalence findings laid down in this Decision should apply to COVID-19 vaccination, test and recovery certificates issued by the Republic of Cabo Verde to Union citizens and their family members. Similarly, on the basis of Regulation (EU) 2021/954, such equivalence findings should also apply to COVID-19 vaccination, test and recovery certificates issued by the Republic of Cabo Verde to third-country nationals legally staying or residing in the territory of the Member States under the conditions laid down in that Regulation.

(3)

On 23 September 2021, the Republic of Cabo Verde provided the Commission with detailed information on the issuance of interoperable COVID-19 vaccination, test and recovery certificates under the system entitled ‘Nha Card’. The Republic of Cabo Verde informed the Commission that it considered that its COVID-19 certificates are being issued in accordance with a standard and a technological system, that are interoperable with the trust framework established by Regulation (EU) 2021/953 and that allow for the verification of the authenticity, validity and integrity of the certificates. In this regard, the Republic of Cabo Verde informed the Commission that COVID-19 vaccination, test and recovery certificates issued by the Republic of Cabo Verde in accordance with the ‘Nha Card’ system contain the data set out in the Annex to Regulation (EU) 2021/953.

(4)

The Republic of Cabo Verde also informed the Commission that it accepts vaccination, test and recovery certificates issued by the Member States and EEA countries in accordance with Regulation (EU) 2021/953.

(5)

On 1 December 2021, following a request by the Republic of Cabo Verde, the Commission carried out technical tests that demonstrated that the COVID-19 vaccination, test and recovery certificates issued by the Republic of Cabo Verde are in accordance with a system, the ‘Nha Card’ that is interoperable with the trust framework established by Regulation (EU) 2021/953, and allows for the verification of the authenticity, validity and integrity of the certificates. The Commission also confirmed that the COVID-19 vaccination, test and recovery certificates issued by the Republic of Cabo Verde in accordance with the ‘Nha Card’ system contain the necessary data.

(6)

In addition, the Republic of Cabo Verde informed the Commission that it issues interoperable vaccination certificates for COVID-19 vaccines. Those vaccines currently include Comirnaty, Spikevax, Vaxzevria, COVID-19 Vaccine Janssen, BBIBP-CorV and Covishield.

(7)

The Republic of Cabo Verde also informed the Commission that it issues interoperable test certificates for nucleic acid amplification tests but not rapid antigen tests.

(8)

Furthermore, the Republic of Cabo Verde informed the Commission that it issues interoperable certificates of recovery. Those certificates are valid for not more than 180 days after the date of the first positive test.

(9)

In addition, the Republic of Cabo Verde informed the Commission that when verifiers in Cabo Verde verify certificates, the personal data included in them will be processed only to verify and confirm the holder’s vaccination, test result or recovery status and will not be retained afterwards.

(10)

The necessary elements for establishing that COVID-19 vaccination, test and recovery certificates issued by the Republic of Cabo Verde in accordance with the ‘Nha Card’ system are to be considered as equivalent to those issued in accordance with Regulation (EU) 2021/953 are thus fulfilled.

(11)

Therefore, COVID-19 vaccination, test and recovery certificates issued by the Republic of Cabo Verde in accordance with the ‘Nha Card’ system should be accepted under the conditions referred to in Article 5(5), Article 6(5) and Article 7(8) of Regulation (EU) 2021/953.

(12)

In order for this Decision to be operational, the Republic of Cabo Verde should be connected to the EU Digital COVID Certificate trust framework established by Regulation (EU) 2021/953.

(13)

In order to protect the Union’s interests, in particular in the area of public health, the Commission may use its powers to suspend application of this Decision or repeal it, if the conditions of Article 8(2) of Regulation (EU) 2021/953 are no longer met.

(14)

In order to connect the Republic of Cabo Verde to the EU Digital COVID Certificate trust framework established by Regulation (EU) 2021/953 as rapidly as possible, this Decision should enter into force on the day of its publication in the Official Journal of the European Union.

(15)

The measures provided for in this Decision are in accordance with the opinion of the Committee established by Article 14 of Regulation (EU) 2021/953,